ออฟไลน์ด้วยแอป Player FM !
พอดคาสต์ที่ควรค่าแก่การฟัง
สปอนเซอร์


Fixing Healthcare Bottlenecks from First Principles: Interview with Enspectra Health CEO Gabriel Sanchez
Manage episode 455966999 series 2926001
In this episode of Medsider Radio, we sat down with Gabriel Sanchez, co-founder and CEO of Enspectra Health. The company's flagship VIO platform is the first FDA-cleared imaging modality for dermatology in over 25 years.
Gabriel holds a B.S. in mechanical engineering from MIT and an M.S. and Ph.D. from Stanford University, where he also served as an instructor in bioengineering and launched Enspectra to commercialize his groundbreaking research. VIO enables high-resolution, noninvasive imaging for skin cancer detection and health biometrics.
In this interview, Gabriel talks about his transition from academia to startups, how he narrowed down his idea to meet a pressing need in healthcare, the importance of speaking FDA’s language—or finding someone who does—and how he balances dilutive and non-dilutive funding.
Before we dive into the discussion, I wanted to mention a few things:
First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.
Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!
We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!
In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.
Lastly, if you'd rather read than listen, here's a link to the full interview with Gabriel Sanchez.
199 ตอน
Fixing Healthcare Bottlenecks from First Principles: Interview with Enspectra Health CEO Gabriel Sanchez
Medsider: Learn from Medtech and Healthtech Founders and CEOs
Manage episode 455966999 series 2926001
In this episode of Medsider Radio, we sat down with Gabriel Sanchez, co-founder and CEO of Enspectra Health. The company's flagship VIO platform is the first FDA-cleared imaging modality for dermatology in over 25 years.
Gabriel holds a B.S. in mechanical engineering from MIT and an M.S. and Ph.D. from Stanford University, where he also served as an instructor in bioengineering and launched Enspectra to commercialize his groundbreaking research. VIO enables high-resolution, noninvasive imaging for skin cancer detection and health biometrics.
In this interview, Gabriel talks about his transition from academia to startups, how he narrowed down his idea to meet a pressing need in healthcare, the importance of speaking FDA’s language—or finding someone who does—and how he balances dilutive and non-dilutive funding.
Before we dive into the discussion, I wanted to mention a few things:
First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.
Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!
We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!
In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.
Lastly, if you'd rather read than listen, here's a link to the full interview with Gabriel Sanchez.
199 ตอน
ทุกตอน
×
1 Building the Beachhead Strategy: Interview with Axena Health Leaders Randy Pritchard and Erica Rogers 55:01

1 A Great Product vs. a Great Business: Interview with EDAP TMS CEO Ryan Rhodes 1:00:47

1 The Hard Truth About Partnerships: Interview with Vivos CEO Kirk Huntsman 1:03:36

1 Is Your Medtech Idea Worth Pursuing?: Interview with BrainSpace CEO Caitlin Morse 1:01:28

1 How to Succeed Without Venture Capital: Interview with Front Line Medical Co-Founders Drs. Asha Parekh and Adam Power 1:04:51

1 Maximize Market Opportunity, Minimize Feedback Loops: Interview with SAVA Co-founders Rafaël Michali and Renato Circi 28:53

1 Fixing Healthcare Bottlenecks from First Principles: Interview with Enspectra Health CEO Gabriel Sanchez 27:01








1 Identifying and Mitigating Key Risk Factors in Medtech Startups: Interview with Adona Medical CEO Brian Fahey 29:27

1 De-Risking Your Way to a Successful Fundraise: Interview with WearLinq CEO Konrad Morzkowski 22:40


1 Managing Critical Risks in Early-Stage Medtech: Interview with Instylla CEO Amarpreet Sawhney 32:11




ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ